Moreno-Pérez, D.; Korobova, A.; Croche-Santander, F.d.B.; Cordón-MartÃnez, A.; DÃaz-Morales, O.; MartÃnez-Campos, L.; Pérez-González, E.; MartÃnez-Padilla, M.d.C.; Santos-Pérez, J.L.; Brioso-Galiana, J.;
et al. Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines 2025, 13, 175.
https://doi.org/10.3390/vaccines13020175
AMA Style
Moreno-Pérez D, Korobova A, Croche-Santander FdB, Cordón-MartÃnez A, DÃaz-Morales O, MartÃnez-Campos L, Pérez-González E, MartÃnez-Padilla MdC, Santos-Pérez JL, Brioso-Galiana J,
et al. Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines. 2025; 13(2):175.
https://doi.org/10.3390/vaccines13020175
Chicago/Turabian Style
Moreno-Pérez, David, Aleksandra Korobova, Francisco de Borja Croche-Santander, Ana Cordón-MartÃnez, Olga DÃaz-Morales, Leticia MartÃnez-Campos, Elena Pérez-González, MarÃa del Carmen MartÃnez-Padilla, Juan Luis Santos-Pérez, Jaime Brioso-Galiana,
and et al. 2025. "Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND)" Vaccines 13, no. 2: 175.
https://doi.org/10.3390/vaccines13020175
APA Style
Moreno-Pérez, D., Korobova, A., Croche-Santander, F. d. B., Cordón-MartÃnez, A., DÃaz-Morales, O., MartÃnez-Campos, L., Pérez-González, E., MartÃnez-Padilla, M. d. C., Santos-Pérez, J. L., Brioso-Galiana, J., Sánchez-Códez, M. I., Del Diego-Salas, J., Rivera-Izquierdo, M., & Lorusso, N.
(2025). Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines, 13(2), 175.
https://doi.org/10.3390/vaccines13020175